Bayer’s CEO calls Sorafenib (cancer drug) Compulsory Licence in India as essential theft

21 Jan 2014

Source: Bloomberg Newsweek
In a news report by Bloomberg Bayer’s CEO Marjin Dekker was quoted saying” We did not develop this medicine for Indians,” Dekkers said Dec. 3. “We developed it for western patients who can afford it.”

Bayer Chief Executive Officer Marijn Dekkers called the compulsory license “essentially theft.”

Read the full article here

This entry was posted in Compulsory Licensing, Indian Patent Law. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s